Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG34982

Ahsa1 Knockout C8D1A Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Mus musculus (Mouse)

  • Tissue Source:

    Brain (cerebellum)

Ahsa1 Knockout C8-D1A Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of mouse cerebellar astrocytes with targeted disruption of Ahsa1, which encodes an Hsp90 co-chaperone that stabilizes client proteins like Akt and Raf. Derived from the C8-D1A line, these knockout cells model chaperone dysfunction in glia, enabling studies of protein folding, stress responses, and neurodegeneration through techniques such as western blotting, co-immunoprecipitation, and client protein stability assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    C8-D1A

    Cell Type

    Astrocyte

    Sex of Donor

    Unknown

    Age

    8 days

    Derived From Site

    Cerebellum

    Gene Name

    AHSA1

    Gene Identifier

    NCBI Gene ID 217737

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The Ahsa1 Knockout C8-D1A Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the C8-D1A mouse cerebellar astrocyte cell line, engineered to disrupt the Ahsa1 gene. This polyclonal knockout model provides a robust loss-of-function system for investigating the role of Ahsa1 in chaperone-mediated protein folding and cellular stress responses. By targeting Ahsa1, researchers can study the functional consequences of impaired Hsp90 chaperone activity in a glial cell context without requiring clonal selection. The polyclonal nature captures genetic heterogeneity, enabling analysis across diverse edit outcomes.

The C8-D1A cell line is an immortalized astrocyte line derived from neonatal C57BL/6 mouse cerebellum. As cerebellar astrocytes, these cells perform essential glial functions in the central nervous system, including providing metabolic support to neurons, maintaining blood-brain barrier integrity, and regulating synaptic transmission. Immortalized astrocytes retain key morphological and functional characteristics of primary astrocytes, offering a physiologically relevant in vitro model for studying glial biology, neuroinflammation, and neurodegenerative disease mechanisms. Their cerebellar origin further positions them for investigations into region-specific astrocyte protein homeostasis and stress vulnerability.

Ahsa1 encodes a co-chaperone that binds directly to Hsp90 and stimulates its ATPase activity, a critical step in the Hsp90 chaperone cycle that drives the maturation and stabilization of a diverse array of client proteins. Within the chaperone machinery, Ahsa1 functions in a multiprotein complex that includes Hsp90, p23, and Cdc37, and its expression is transcriptionally upregulated by HSF1 in response to heat shock, oxidative stress, and proteotoxic insults. Downstream, the Hsp90-Ahsa1 axis controls the stability of key signaling molecules such as the kinases Akt and Raf, steroid hormone receptors, and the hypoxia-inducible factor HIF-1??. Disruption of Ahsa1 impairs Hsp90 ATPase function, leading to reduced client protein stability, altered chaperone cycle dynamics, and compromised cellular adaptation to stress.

In the context of cerebellar astrocytes, Ahsa1 knockout is particularly significant for understanding how chaperone dysfunction impacts glial cell physiology. Astrocytes rely on robust protein quality control mechanisms to maintain their supportive roles, and loss of Ahsa1-mediated Hsp90 activation may render these cells susceptible to proteotoxic stress and impair their ability to sustain neuronal health. This model enables detailed investigation of the specific contributions of Ahsa1 to astrocyte functions such as metabolic support, blood-brain barrier maintenance, and synaptic regulation under basal and stress conditions. It also provides a valuable platform for probing the role of glial protein misfolding in neurodegenerative disorders, where astrocyte dysfunction is increasingly recognized as a contributing factor.

This polyclonal knockout cell population is well-suited for a wide range of experimental applications, including mechanistic studies of chaperone-mediated protein folding in astrocytes, analysis of Hsp90 client protein stability, and modeling of neurodegenerative diseases linked to protein aggregation and cellular stress. The cells can be employed in assays such as western blotting to monitor client protein levels, co-immunoprecipitation to examine Ahsa1-Hsp90 complex formation, Hsp90 ATPase activity measurements, quantitative PCR for heat shock response genes, immunofluorescence to visualize chaperone localization, and client protein stability assays under proteotoxic stress conditions. For additional information or technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)